Angewandte
Chemie
DOI: 10.1002/anie.201108002
Enzyme Mechanisms
Insights into the Mechanism of the Antibiotic-Synthesizing Enzyme
MoeO5 from Crystal Structures of Different Complexes**
Feifei Ren, Tzu-Ping Ko, Xinxin Feng, Chun-Hsiang Huang, Hsiu-Chien Chan, Yumei Hu,
Ke Wang, Yanhe Ma, Po-Huang Liang, Andrew H.-J. Wang, Eric Oldfield,* and Rey-Ting Guo*
The phosphoglycolipid antibiotic moenomycin directly blocks
bacterial cell-wall biosynthesis by inhibiting peptidoglycan
glycosyltransferases.[1] The enzyme MoeO5, encoded by the
moe gene cluster 1 in Streptomyces ghanaensis, catalyzes the
initial step of moenomycin production, in which the C15-
hydrocarbon moiety of farnesyl pyrophosphate (FPP) is
transferred to the 2-hydroxy group of 3-phosphoglycerate
(3PG), forming an ether bond (Scheme 1).[2] The reaction is
similar to that catalyzed by geranylgeranylglyceryl phosphate
synthase (GGGPS) for synthesizing archaea-type phospho-
lipids.[3] However, in contrast to the enzyme GGGPS, which
gives products with retained all-trans configuration of the
isoprenyl chain, the enzyme MoeO5 leads to a trans-to-cis
=
isomerization at the C2 C3 double bond of the transferred
farnesyl group.[4] The crystal structures of the proteins
GGGPS and the bacterial homologue PcrB reveal a triose-
phosphate isomerase (TIM)-barrel fold, which had not been
observed previously in prenyltransferases.[3,5] The sequences
of GGGPS and PcrB share 35% amino acid identity, but
MoeO5 shares only 10% identity with both enzymes (Fig-
ure S1 in the Supporting Information). Herein we report the
X-ray crystallographic structures of MoeO5 bound to the
product 2-(Z,E)-farnesyl-3-phosphoglycerate (FPG), to the
substrate analogue farnesyl thiopyrophosphate (FsPP), and to
magnesium (Mg2+) and pyrophosphate (PPi); together with
additional biochemical and bioinformatics results, these
structures shed light on the possible mechanisms of action
of this unusual enzyme.
Molecular-replacement approaches to determine the
structure of MoeO5 by using GGGPS and PcrB as search
models were not successful, thereby reflecting perhaps the
significant variations in the protein sequences. Because
MoeO5 contains no Cys residue, to solve the structure by
using multiple isomorphous replacement (MIR), we pro-
duced the mutant H97C for efficient preparation of mercury-
based MIR derivatives (Table S1 in the Supporting Informa-
tion). The other structures were solved by molecular replace-
ment (Figure S2 in the Supporting Information and Table 1;
see the Supporting Information for details). MoeO5 crystal-
lizes as a homodimer (Figure S3 and Table S2 in the
Supporting Information). The dimer interface buries
1200 ꢀ2, which is more than 10% surface area, on each
monomer and mainly involves hydrophobic residues in
helices a4 and a5. The cis-peptide of Phe140–Pro141 binds
to a Mg2+ at the molecular dyad (Figure S3 in the Supporting
Information). These helices also mediate dimerization in
GGGPS and PcrB, but in MoeO5 one of the TIM barrels is
rotated by 1808 (Figure S4 in the Supporting Information). A
more detailed description of the protein structure as well as of
the bound ligands can be found in the Supporting Informa-
tion. Despite its Ca root-mean-square deviation (r.m.s.d.) of
about 2.0 ꢀ from the GGGPS and PcrB monomers (Figure S5
in the Supporting Information), the similar protein fold with
a connecting loop (denoted l3) between strands b3 and b4
clearly places MoeO5 among this new class of TIM-barrel
prenyltransferases.
Scheme 1. The first step in moenomycin biosynthesis. The reaction is
catalyzed by MoeO5, which transfers the C15 farnesyl group from FPP
to 3PG. The carbon atoms are numbered 1–15 in FPP and 1’–3’ in
3PG. Importantly, the original all-trans configuration is converted to
2-cis,6-trans (Z,E) upon the farnesyl transfer, thereby forming 2-(Z,E)-
farnesyl-3-phosphoglycerate (FPG) and pyrophosphate ion (PPi).
[*] F. Ren,[+] Dr. C.-H. Huang, Dr. H.-C. Chan, Y. Hu, Prof. Dr. Y. Ma,
Prof. Dr. R.-T. Guo
Industrial Enzymes National Engineering Laboratory
Tianjin Institute of Industrial Biotechnology
Chinese Academy of Sciences, Tianjin 300308 (China)
E-mail: guo_rt@tib.cas.cn
Dr. T.-P. Ko,[+] Prof. Dr. P.-H. Liang, Prof. Dr. A. H.-J. Wang
Institute of Biological Chemistry, Academia Sinica
Taipei 11529 (Taiwan)
X. Feng, Dr. K. Wang, Prof. Dr. E. Oldfield
Department of Chemistry, University of Illinois
Urbana, IL 61801 (USA)
E-mail: eo@chad.scs.uiuc.edu
[+] These authors contributed equally to this work.
[**] This work was supported by the National Basic Research Program of
China (grant 2011CB710800 to R.T.G.), Tianjin Municipal Science
and Technology Commission (10ZCKFSY06000 to R.T.G.), and the
National Institutes of Health (AI074233 to E.O.). We thank the
National Synchrotron Radiation Research Center of Taiwan for
beam-time allocation and data-collection assistance.
The wild-type MoeO5 cocrystallized with a bound product
FPG, in which the C15 tail moiety makes a U-turn mainly at
Supporting information for this article is available on the WWW
Angew. Chem. Int. Ed. 2012, 51, 4157 –4160
ꢀ 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
4157